|
|
|
LifeScienceHistory.com - Check us out on Instagram
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Teva API, Inc.
| | | Phone: | (973) 265-3600 | Fax: | (973) 265-3681 | Year Established: | 1901 | Ticker: | TEVA | Exchange: | NYSE | Main Contact: | Kåre Schultz, President & CEO | | Other Contacts: | Sven Dethlefs, Executive VP, Global Marketing & Portfolio Hafrun Fridriksdottir, Ph.D., Executive VP, R&D Michael (Mike) McClellan, Executive VP & CFO Brendan O'Grady, Executive VP, North America Commercial David M. Stark, Executive VP & CLO Lori Queisser, Senior VP & & Global Compliance Officer
| | Company Description | Teva API, formerly Plantex USA, is a leading generic pharmaceutical company, marketing products from a wide range of therapeutic areas including cardiovascular, anti-infective, CNS, anti-inflammatory, oncolytic, antidiabetic, analgesic, dermatology, respiratory, and female healthcare. Dosage forms include tablets and capsules, injectables, creams, ointments, inhalants, solutions, and suspensions. | |
|
|
|
|
|